Drug Profile
AG 13958
Alternative Names: AG-013,958; AG-13958Latest Information Update: 11 Mar 2008
Price :
$50
*
At a glance
- Originator Pfizer
- Class Eye disorder therapies
- Mechanism of Action Angiogenesis inhibitors; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Age-related macular degeneration
Most Recent Events
- 11 Mar 2008 Discontinued - Phase-I/II for Age-related macular degeneration in Australia (Ophthalmic)
- 11 Mar 2008 Discontinued - Phase-I/II for Age-related macular degeneration in Netherlands (Ophthalmic)
- 11 Mar 2008 Discontinued - Phase-I/II for Age-related macular degeneration in United Kingdom (Ophthalmic)